Requirements Analysis and Specification for a Molecular Tumor Board Platform Based on cBioPortal.

cBioPortal computational biology decision making, computer-assisted decision support systems, clinical molecular tumor board neoplasms precision medicine requirements analysis

Journal

Diagnostics (Basel, Switzerland)
ISSN: 2075-4418
Titre abrégé: Diagnostics (Basel)
Pays: Switzerland
ID NLM: 101658402

Informations de publication

Date de publication:
10 Feb 2020
Historique:
received: 15 12 2019
revised: 21 01 2020
accepted: 07 02 2020
entrez: 14 2 2020
pubmed: 14 2 2020
medline: 14 2 2020
Statut: epublish

Résumé

Clinicians in molecular tumor boards (MTB) are confronted with a growing amount of genetic high-throughput sequencing data. Today, at German university hospitals, these data are usually handled in complex spreadsheets from which clinicians have to obtain the necessary information. The aim of this work was to gather a comprehensive list of requirements to be met by cBioPortal to support processes in MTBs according to clinical needs. Therefore, oncology experts at nine German university hospitals were surveyed in two rounds of interviews. To generate an interview guideline a scoping review was conducted. For visual support in the second round, screenshot mockups illustrating the requirements from the first round were created. Requirements that cBioPortal already meets were skipped during the second round. In the end, 24 requirements with sometimes several conceivable options were identified and 54 screenshot mockups were created. Some of the identified requirements have already been suggested to the community by other users or are currently being implemented in cBioPortal. This shows, that the results are in line with the needs expressed by various disciplines. According to our findings, cBioPortal has the potential to significantly improve the processes and analyses of an MTB after the implementation of the identified requirements.

Identifiants

pubmed: 32050609
pii: diagnostics10020093
doi: 10.3390/diagnostics10020093
pmc: PMC7167859
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : German Federal Ministry of Education and Research (BMBF)
ID : FKZ 01ZZ1801A
Organisme : German Federal Ministry of Education and Research (BMBF)
ID : FKZ 01ZZ1801B

Déclaration de conflit d'intérêts

The authors declare no conflicts of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.

Références

JCO Precis Oncol. 2018 Aug 16;2:
pubmed: 32913998
JCO Precis Oncol. 2017 Jul;2017:
pubmed: 28890946
Assay Drug Dev Technol. 2017 Aug/Sep;15(6):247-256
pubmed: 28837357
Oncotarget. 2017 Apr 18;8(16):27145-27154
pubmed: 28423702
Hum Genomics. 2016 Jan 16;10:4
pubmed: 26772741
PLoS Med. 2009 Jul 21;6(7):e1000097
pubmed: 19621072
PLoS Med. 2009 Jul 21;6(7):e1000100
pubmed: 19621070
Methods Mol Biol. 2017;1613:101-124
pubmed: 28849560
Cancer Discov. 2012 May;2(5):401-4
pubmed: 22588877
Nat Genet. 2017 Jan 31;49(2):170-174
pubmed: 28138153
J Oncol Pract. 2015 Nov;11(6):442-9
pubmed: 26243651
Sci Signal. 2013 Apr 02;6(269):pl1
pubmed: 23550210
Stud Health Technol Inform. 2017;236:48-54
pubmed: 28508778
Genome Med. 2018 Mar 15;10(1):18
pubmed: 29544535
Methods Inf Med. 2018 Jul;57(S 01):e82-e91
pubmed: 30016814

Auteurs

Philipp Buechner (P)

Department of Medical Informatics, Friedrich-Alexander-University Erlangen-Nürnberg (FAU), 91058 Erlangen-Tennenlohe, Germany.

Marc Hinderer (M)

Department of Medical Informatics, Friedrich-Alexander-University Erlangen-Nürnberg (FAU), 91058 Erlangen-Tennenlohe, Germany.

Philipp Unberath (P)

Department of Medical Informatics, Friedrich-Alexander-University Erlangen-Nürnberg (FAU), 91058 Erlangen-Tennenlohe, Germany.

Patrick Metzger (P)

Institute of Medical Bioinformatics and Systems Medicine, Faculty of Medicine and Medical Center-University of Freiburg, 79110 Freiburg, Germany.
Faculty of Biology, University of Freiburg, 79104 Freiburg, Germany.

Martin Boeker (M)

Institute of Medical Biometry and Statistics, Faculty of Medicine and Medical Center, University of Freiburg, 79104 Freiburg, Germany.

Till Acker (T)

Institute of Neuropathology, Justus-Liebig-University Giessen, 35392 Giessen, Germany.

Florian Haller (F)

Institute of Pathology, University Hospital Erlangen, 91054 Erlangen, Germany.

Elisabeth Mack (E)

Department of Hematology, Oncology and Immunology, Philipps-University Marburg, and University Hospital Gießen and Marburg, Marburg, Germany Baldingerstraße.

Daniel Nowak (D)

Department of Hematology and Oncology, Medical Faculty Mannheim, Heidelberg University, 68167 Mannheim, Germany.
Heinrich-Lanz-Center for digital health, Medical Faculty Mannheim, Heidelberg University, 68167 Mannheim, Germany.

Claudia Paret (C)

Pediatric Hematology/Oncology, Children's Hospital, University Medical Center of the Johannes Gutenberg-University Mainz, 55131 Mainz, Germany.
University Cancer Center (UCT) of the University Medical Center of the Johannes Gutenberg-University Mainz, 55131 Mainz, Germany.

Denny Schanze (D)

Institute of Human Genetics, University Hospital Magdeburg, Faculty of Medicine, Otto-von-Guericke University, 39120 Magdeburg, Germany.

Nikolas von Bubnoff (N)

Department of Hematology and Oncology, Medical Center, University of Schleswig-Holstein, Campus Lübeck, 23538 Lübeck, Germany.
German Cancer Consortium (DKTK), partner site Freiburg, 79106 Freiburg, Germany.
Department of Hematology, Oncology and Stem Cell Transplantation, Medical Center, Faculty of Medicine, University of Freiburg, 79106 Freiburg, Germany.

Sebastian Wagner (S)

Department of Medicine 2, Hematology/Oncology, Goethe University Hospital, 60590 Frankfurt am Main, Germany.

Hauke Busch (H)

Institute of Experimental Dermatology and Institute of Cardiogenetics, University of Lübeck, 23562 Lübeck, Germany.

Melanie Boerries (M)

Institute of Medical Bioinformatics and Systems Medicine, Faculty of Medicine and Medical Center-University of Freiburg, 79110 Freiburg, Germany.
Comprehensive Cancer Center Freiburg (CCCF), Faculty of Medicine and Medical Center - University of Freiburg, 79106 Freiburg, Germany.
German Cancer Consortium (DKTK), partner site Freiburg.

Jan Christoph (J)

Department of Medical Informatics, Friedrich-Alexander-University Erlangen-Nürnberg (FAU), 91058 Erlangen-Tennenlohe, Germany.

Classifications MeSH